Sutter Martin P's Form 4 filing
Abiomed Inc (ABMD) · filed Feb 17, 2022
- Accession no.
- 0001179110-22-001397
- Filed
- Feb 17, 2022
- Trade date
- Feb 15, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 9 non-derivative transactions and 0 derivative transactions. Open-market sales total $607.3K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Sutter Martin PCIK 0001017832 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 15, 2022 | Common Stock, $0.01 par value | SSaleDisposed | −11 | $296.18 | −$3,257.98 | 138,379 | Direct | |
| Feb 15, 2022 | Common Stock, $0.01 par value | SSaleDisposed | −32 | $298.50 | −$9,552 | 138,347 | Direct | |
| Feb 15, 2022 | Common Stock, $0.01 par value | SSaleDisposed | −157 | $301.00 | −$47,257 | 138,190 | Direct | |
| Feb 15, 2022 | Common Stock, $0.01 par value | SSaleDisposed | −159 | $301.56 | −$47,948.04 | 138,031 | Direct | |
| Feb 15, 2022 | Common Stock, $0.01 par value | SSaleDisposed | −312 | $302.70 | −$94,442.4 | 137,719 | Direct | |
| Feb 15, 2022 | Common Stock, $0.01 par value | SSaleDisposed | −460 | $303.65 | −$139,679 | 137,259 | Direct | |
| Feb 15, 2022 | Common Stock, $0.01 par value | SSaleDisposed | −536 | $304.52 | −$163,222.72 | 136,723 | Direct | |
| Feb 15, 2022 | Common Stock, $0.01 par value | SSaleDisposed | −185 | $305.71 | −$56,556.35 | 136,538 | Direct | |
| Feb 15, 2022 | Common Stock, $0.01 par value | SSaleDisposed | −148 | $306.68 | −$45,388.64 | 136,390 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.